Welcome to our dedicated page for Expion360 SEC filings (Ticker: XPON), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Before buying shares in a lithium-battery specialist, most investors hunt for answers buried in technical reports. With Expion360’s focus on minimal-footprint LiFePO4 packs for RV, marine, and home storage, disclosures often span hundreds of pages. Our platform gathers every Expion360 SEC filing in one place and makes sense of it—so you don’t spend evenings decoding chemistry jargon.
What you can do here:
- Open the latest Expion360 quarterly earnings report 10-Q filing and see AI-generated highlights of segment revenue trends.
- Track Expion360 insider trading Form 4 transactions; real-time alerts flag each Expion360 Form 4 insider transactions real-time entry.
- Dive into the Expion360 annual report 10-K simplified by our AI, complete with cash-flow callouts and battery production cost breakdowns.
- Receive concise briefs when an Expion360 8-K material events explained hits EDGAR—supply-chain deals, OEM partnerships, or leadership changes.
Want quick answers? Type a natural question—“understanding Expion360 SEC documents with AI� or “Expion360 earnings report filing analysis”—and our models surface the exact note, table, or risk factor. Curious about pay packages? The Expion360 proxy statement executive compensation summary highlights stock options and performance metrics in minutes.
By linking filing types to what matters for this battery manufacturer—lithium sourcing costs, capacity expansion, warranty reserves—Stock Titan turns raw documents into practical insight. From Expion360 executive stock transactions Form 4 to footnotes on forthcoming e360 Home Energy Storage lines, every detail is delivered clearly, confidently, and in real time.
Expion360 reported meaningful sales growth but remains loss-making with material liquidity and listing risks. Net sales rose to $2.99 million for the three months ended June 30, 2025, up 134% from $1.28 million a year earlier, and to $5.04 million for the six months, up 124% versus 2024. Gross profit improved, and net loss narrowed to $1.37 million for the quarter (a 38% improvement) and $2.52 million for six months (a 43% improvement). Cash and cash equivalents were $684,920 at June 30, 2025, and the company carried an accumulated deficit of $37.1 million. Management disclosed substantial doubt about the company’s ability to continue as a going concern. The company completed a January 2025 public offering that generated $2.60 million gross ($1.78 million net) and used $500,000 toward a suspended reverse-split cash true-up, leaving a suspended liability of $4.49 million. Customer concentration remains high (two customers = ~53% of quarterly sales). On July 1, 2025 Nasdaq staff determined the company failed the $1.00 minimum bid price rule and initiated delisting proceedings; a hearing is scheduled for August 19, 2025.
Expion360 Inc. announced that it furnished a press release and investor presentation reporting financial results for the fiscal quarter ended June 30, 2025 and will host a conference call to discuss those results.
The company confirmed it has regained compliance with Nasdaq Listing Rule 5550(a)(2) after its common stock closed above $1.00 for the required period, so its shares remain listed and traded on The Nasdaq Capital Market; a previously scheduled appeal hearing was cancelled.
Expion360 (XPON) Form 4 filed 1-Aug-25 details insider equity awards to director Tien Q. Nguyen. On 31-Jul-25 Nguyen received 5,000 restricted stock units that vested immediately; each RSU converts into one common share at no cost. The filing also discloses a simultaneous grant of 5,000 stock options exercisable at $0.9329, the board-approved closing price. The options vested in full on the grant date and expire 31-Jul-35.
Post-transaction, the director’s beneficial ownership totals 10,122 shares/equivalents: 122 shares held outright, 5,000 vested RSUs and 5,000 option shares exercisable within 60 days. No dispositions or cash purchases occurred.
The grants were enabled by shareholder approval of an increase in shares available under the 2021 Incentive Award Plan. While the aggregate 10,000 new rights are modest versus XPON’s float, they signal tighter director-company alignment and introduce a small potential dilution over time.
FAQ
What is the current stock price of Expion360 (XPON)?
What is the market cap of Expion360 (XPON)?
